Shree Ganesh Remedies Ltd l IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| NII (HNI) | — | 1,125,000 (47%) | — | ₹405 Cr |
| Retail | — | 1,125,000 (47%) | — | ₹405 Cr |
| Market Maker | — | 126,000 (5%) | — | ₹5 Cr |
| Σ Total | — | 2,376,000 (100%) | — | ₹8,554 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 3,000 | ₹108,000 |
| Retail (Max) | 13 | 39,000 | ₹1,404,000 |
| S-HNI (Min) | 14 | 42,000 | ₹1,512,000 |
| B-HNI (Min) | 67 | 201,000 | ₹7,236,000 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- Setting up a new Choloro Compound derivatives manufacturing plant with a proposed capacity of 200 MTPA at Ankleshwar GIDC Gujarat – 8.56
- General Corporate Purposes – 1.12
Company Overview
Incorporated in 1995, Shree Ganesh Remedies Ltd is Ankleshwar, Gujarat based engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride and specialty fine chemicals for pharmaceutical industry. Company manufacture products relating to antipsychotic, antiseptic, deprotonation reactions, hyperlipidemia, alzheimers and anti-viral.
The Products are manufactured for export market and also for domestic and foreign markets. Company’s manufacturing facility is divided into three manufacturing plants namely Plant I, II and III spread across 9715 Square meters having different product manufacturing capabilities and process.